Takeda Pharmaceutical Company Limited American Depositary ShTAK
Close of Friday, October 23, 2026 · Takeda Pharmaceutical Company Limited American Depositary Sh is trading above its Pivot, OnlyAlpha's long-term trend line.
Price
$20.24
vs its Pivot
+16.0%
OnlyAlpha Score
85
Trend
Above its Pivot
Last 12 months. Solid line: price. Dashed green: the Pivot.
Returns
| 1 month | Year to date | 1 year | 3 years / yr | 5 years / yr |
|---|---|---|---|---|
| +8.9% | +29.8% | +43.1% | +13.9% | +8.9% |
No dividend in the last 12 months.
Suppliers, customers and partners
Sells to TAK
| Halozyme | ENHANZE license |
| Exelixis | cabozantinib royalties $60.3M cumulative |
Partners and deals
| Arrowhead Pharmaceuticals | fazirsiran US 50/50 profit share |
From the companies' own annual reports filed with the SEC.
Healthcare · Pharma
Get TAK in your free daily emailAfter every close: whether TAK is above or below its Pivot, its OnlyAlpha Score, and any new buy or sell signal, along with the rest of your list.
Track TAK free → Full Stock check
Track TAK free → Full Stock check